Rapid, Simple Assay for Ziprasidone Mesylate in Extemporaneously Compounded Oral Solutions

Parish, Roy C

Abstract

Rapid, Simple Assay for Ziprasidone Mesylate in Extemporaneously Compounded Oral Solutions

Author(s): Parish Roy C

Issue: Nov/Dec 2009 - Geriatric Compounding

View All Articles in Issue

Page(s): 572-573

Download in electronic PDF format for $75

Abstract

A high-performance liquid chromatographic assay method was developed to facilitate stability studies of extemporaneously compounded oral liquid formulations of ziprasidone. The method is simple and precise within the needs of the pharmaceutical profession. The throughput time is approximately 7 minutes per sample. The method is easily adaptable for individual needs.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Nov/Dec 2009 Pg. 572-573	Rapid, Simple Assay for Ziprasidone Mesylate in Extemporaneously Compounded Oral Solutions Author(s): Parish Roy C
Nov/Dec 2021 Pg. 509	Ziprasidone Mesylate 2.5 mg/mL in Ora-Sweet Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2001 Pg. 310-312	Wetting and/or Solubilizing Agents, Featured Excipient: Author(s): Allen Loyd V Jr
May/Jun 2004 Pg. 181-185	Compounding in the Pharmacy Curriculum: Beyond the Basics Author(s): Hinkle Amanda R, Newton Gail D
May/Jun 2009 Pg. 254-258	Stability of Pergolide Mesylate Oral Liquid at Room Temperature Author(s): Shank Brandon R, Ofner Clyde M III
Jul/Aug 2002 Pg. 255-256	Aminophylline 3%, Co-dergocrine Mesylate 0.05%, and Isosorbide Dinitrate 0.25% Cream for the Treatment of Orgasmic Dysfunction in Women Author(s): Mason Dave
Sep/Oct 1997 Pg. 339	Assaying Progesterone in Extemporaneously Prepared Suppositories Author(s): Al-Achi Antoine, Webster Kathy, Greenwood Robert, Nicol Scott
May/Jun 2007 Pg. 251	Trovafloxacin Mesylate 10-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Sep/Oct 2018 Pg. 410	Pergolide Mesylate 0.2-mg/mL Oral Liquid, Veterinary Author(s): Allen Loyd V Jr
Nov/Dec 2013 Pg. 498	Benztropine Mesylate 1-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2015 Pg. 69	Phentolamine Mesylate 5-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2004 Pg. 46-48	Basics of Compounding for Disorders of the External Ear Author(s): Allen Loyd V Jr
Mar/Apr 2015 Pg. 144	Deferoxamine Mesylate 213/mg/mL or 95-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 318	Dolasetron Mesylate 20-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2013 Pg. 503	Dihydroergotamine Mesylate 1-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2017 Pg. 164-170	Development and Application of a High-Performance Liquid Chromatography Stability-Indicating Assay for Beyond-Use Date Determination of Compounded Topical Gels Containing Multiple Active Drugs Author(s): Gorman Gregory, Sokom Simara, Coward Lori, Arnold John J
May/Jun 2018 Pg. 240-246	Investigation of the Physical, Chemical, and Microbiological Stability of Oral Solutions Compounded with Herbals Author(s): Khokhlova Kateryna O, Zdoryk Oleksandr A
Jul/Aug 2010 Pg. 340	Fenoldopam Mesylate Injection Author(s): Allen Loyd V Jr
Jan/Feb 2001 Pg. 9-12	Stability Issues for Compounding Extemporaneously Prepared Oral Formulations for Pediatric Patients Author(s): Schotik Debora
Jan/Feb 2019 Pg. 62-64	Chemical Stability of Progesterone in Compounded Oral Rapid-dissolving Tablets Author(s): Sayre Casey L, Cox Christopher, Velazquez Gabriel, Le Minh Thi, Nguyen Amy Hong, Ramos Marjorie, Burrows Anna, Yellepeddi Venkata Kashyap